Back
Kaival Brands Innovations Group Vs. Regencell Bioscience Holdings Industry Stock Comparison
Sell
19
KAVL
Kaival Brands Innovations Group
Last Price:
$0.55
Seasonality Move:
668.09%
Sell
50
RGC
Regencell Bioscience Holdings
Last Price:
$57.52
Seasonality Move:
5.37%
Sell
19
Kaival Brands Innovations Group (KAVL)
is a Sell
Is Kaival Brands Innovations Group a Buy, Sell or Hold?
-
The current Kaival Brands Innovations Group [KAVL] share price is $0.57. The Score for KAVL is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
KAVL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
50
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $58.63. The Score for RGC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KAVL Stock Price Chart
What is Kaival Brands Innovations Group's stock price today?
-
The Kaival Brands Innovations Group share price today is $0.57Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KAVL is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $58.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing slight buying pressure.
KAVL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 28.89 | Sell |
Chaikin Money Flow: | 79059 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.6 - 0.98) | Sell |
Bollinger Bands (100): | (0.71 - 1.15) | Sell |
RGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.59 | Buy |
Relative Strength Index (14 RSI): | 95.36 | Buy |
Chaikin Money Flow: | 167065 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-2.84 - 25.82) | Buy |
Bollinger Bands (100): | (-0.8 - 14.58) | Buy |
KAVL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.6 | Sell |
20-day SMA: | 0.72 | Sell |
50-day SMA: | 1 | Sell |
200-day SMA: | 1.05 | Sell |
8-day EMA: | 0.61 | Sell |
20-day EMA: | 0.73 | Sell |
50-day EMA: | 0.88 | Sell |
200-day EMA: | 1.63 | Sell |
RGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.93 | Buy |
20-day SMA: | 13.41 | Buy |
50-day SMA: | 7.93 | Buy |
200-day SMA: | 6.53 | Buy |
8-day EMA: | 31.97 | Buy |
20-day EMA: | 18.83 | Buy |
50-day EMA: | 11.05 | Buy |
200-day EMA: | 7.63 | Buy |
Kaival Brands Innovations Group Earnings Growth & KAVL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kaival Brands Innovations Group Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regencell Bioscience Holdings Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |